Becker's cites FDA and Eli Lilly reports on the deaths, which add to concerns over illicit versions of the unapproved weight loss drug.
Recap by typeshit. Full story at Becker's Hospital Review.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Users describe migraines, eye pain and months of fatigue, as an FDA advisory panel stacked with industry-tied doctors votes to ease limits on six unapproved peptides.
Gelita, Rousselot and Puredia describe demand moving toward precise collagen systems. Rousselot notes GHK-Cu still lacks solid human trial data.
Loading…